PER percheron therapeutics limited

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-185

  1. 35,790 Posts.
    lightbulb Created with Sketch. 555
    again though that is each parents decision they are not not unaware of these things - if anything they are more over it than anybody & the sales will reflect it ….

    and that’s a key point i’ve made previously about the longevity of the 1 time treatment & whether it will need top ups - but that will only be seen in time …

    “Ghost data” if you like - or you can wait 10 years ?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.9¢
Change
0.000(0.00%)
Mkt cap ! $9.786M
Open High Low Value Volume
0.9¢ 0.9¢ 0.9¢ $1.62K 180K

Buyers (Bids)

No. Vol. Price($)
4 364826 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 8026021 8
View Market Depth
Last trade - 10.37am 25/07/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.